Doctor Consultation

This is the second blog in the Movember series. Movember is the leading charity changing the face of Men's Health. Their story started 20 years ago with a few friends, some moustache's and a cheque to the Prostate Cancer Foundation of Australia.

Exploring the Power of RNA-based Technologies

In the world of molecular biology, RNA-based technologies have emerged as a powerful toolbox that enables scientists to decipher the intricacies of life at the molecular level.

5 Upcoming Liquid Biopsy Trends in 2023

With robot servers, the metaverse, and automation, it is clear that we’ve officially entered the era of advanced technology. This is also true for the life sciences industry.

Norgen researchers in our laboratory

A group of researchers from the Institute of Health Carlos III (ISCIII) in Spain, presented a poster at the annual meeting for the International Society of Extracellular Vesi

scientist looking through microscope

Currently, there is limited technology available for accurately predicting high-risk cancer biochemical recurrence (BCR).

artist rendering of Activated-Specialized Tissue Effector Cells and human heart

Cell therapy using cardiosphere-derived cells (CDCs) is an increasingly promising treatment for acute and congenital heart muscle injuries, including myocardial infarction (MI).

artist rendering of semi-transparent human covering face with back of hand with brain and skeleton visible.

The National Institute of Health estimates that approximately 6 in 100 000 individuals develop brain or central nervous system-related cancers each year1. Current approaches in the diagnosis of brain cancer include CT scans, MRI and tissue biopsy.

Artist rendering renal inflammatory pathway

RNA isolation and quantification of miRNAs are gaining significance as promising methods in cancer biomarker discovery.